NVO — Novo Nordisk A/S Balance Sheet
0.000.00%
Last trade - 00:00
- $561.98bn
- $561.14bn
- DKK232.26bn
- 100
- 11
- 70
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14,966 | 12,104 | 16,362 | 23,116 | 29,373 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 29,152 | 32,184 | 46,799 | 57,505 | 75,261 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 62,456 | 65,809 | 85,595 | 108,194 | 139,646 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 50,551 | 50,269 | 55,362 | 66,671 | 90,961 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 125,612 | 144,922 | 194,508 | 241,257 | 314,486 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58,983 | 70,273 | 99,516 | 120,940 | 169,655 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 68,019 | 81,597 | 123,762 | 157,771 | 207,925 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 57,593 | 63,325 | 70,746 | 83,486 | 106,561 |
Total Liabilities & Shareholders' Equity | 125,612 | 144,922 | 194,508 | 241,257 | 314,486 |
Total Common Shares Outstanding |